Menorah Medical Center is an acute care hospital located in Overland Park, Kansas at 5721 West 119th Street. It is part of the HCA Midwest Division.

There are 155 beds in Menorah Medical Center.

During the past decade, Menorah Medical Center conducted 78 clinical trials. In the 10-year time frame, 78 clinical trials started and 126 clinical trials were completed, i.e. on average, 161.5% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 65 clinical trials were completed. i.e. 590.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Menorah Medical Center" #1 sponsor was "National Cancer Institute (NCI)" with 80 trials, followed by "SWOG Cancer Research Network" with 51 trials sponsored, "Alliance for Clinical Trials in Oncology" with 35 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 10 trials sponsored and "Gynecologic Oncology Group" with 10 trials sponsored. Other sponsors include 34 different institutions and companies that sponsored additional 23 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Menorah Medical Center" #1 collaborator was "National Cancer Institute (NCI)" with 129 trials as a collaborator, "NRG Oncology" with 18 trials as a collaborator, "NCIC Clinical Trials Group" with 8 trials as a collaborator, "SWOG Cancer Research Network" with 8 trials as a collaborator and "Cancer and Leukemia Group B" with 7 trials as a collaborator. Other collaborators include 81 different institutions and companies that were collaborators in the rest 59 trials.

According to Clinical.Site data, the most researched conditions in "Menorah Medical Center" are "Breast Cancer" (19 trials), "Colorectal Cancer" (10 trials), "Lung Cancer" (10 trials), "Lymphoma" (10 trials) and "Recurrent Squamous Cell Lung Carcinoma" (9 trials). Many other conditions were trialed in "Menorah Medical Center" in a lesser frequency.

Most popular intervention types in "Menorah Medical Center" are "Drug" (165 trials), "Other" (134 trials), "Biological" (74 trials), "Procedure" (36 trials) and "Radiation" (25 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (73 trials), "Quality-of-Life Assessment" (39 trials), "Paclitaxel" (19 trials), "Carboplatin" (18 trials) and "Questionnaire Administration" (17 trials). Other intervention names were less common.

The vast majority of trials in "Menorah Medical Center" are 177 trials for "All" genders, 42 trials for "Female" genders and 6 trials for "Male" genders.

Currently, there are NaN active trials in "Menorah Medical Center". 2 are not yet recruiting, 13 are recruiting, 96 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 96 completed trials in Menorah Medical Center, 1 suspended trials, and 12 terminated clinical trials to date.

Out of the total trials that were conducted in Menorah Medical Center, 7 "Phase 1" clinical trials were conducted, 89 "Phase 2" clinical trials and 105 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 12 trials that are defined as “Not Applicable".